We're sorry, but eCampus.com doesn't work properly without JavaScript.
Either your device does not support JavaScript or you do not have JavaScript enabled.
How to enable JavaScript in your browser.
Need help? Call 1-855-252-4222
Note: Supplemental materials are not guaranteed with Rental or Used book purchases.
Purchase Benefits
What is included with this book?
A global perspective on the management and prevention of emerging and re-emerging diseases
Emerging infectious diseases are newly identified or otherwise previously unknown infections that cause public health challenges. Re-emerging infectious diseases are due to both the reappearance of and an increase in the number of infections from a disease that is known, but which had formerly caused so few infections that it was no longer considered a public health problem. The factors that cause the emergence or re-emergence of a disease are diverse.
This book takes a look at the world's emerging and re-emerging diseases. It covers the diagnosis, therapy, prevention, and control of a variety of individual diseases, and examines the social and behavioral issues that could contribute to epidemics. Each chapter focuses on an individual disease and provides scientific background and social history as well as the current basics of infection, epidemiology, and control.
Emerging Epidemics: Management and Control offers five topics of coverage:
FUNDAMENTALS
RE-EMERGING EPIDEMICS
NEWLY EMERGING EPIDEMICS
POTENTIAL EPIDEMICS
VECTOR CONTROL METHODS
Offering an integrated, worldwide overview of the complexity of the epidemiology of infections, Emerging Epidemics will be a valuable resource for students, physicians, and scientists working in veterinary, medical, and the pharmaceutical sciences.
Prakash Singh Bisen, PhD, D.Sc, is an eminent scientist in the field of Biotechnology with over 32 years of research and teaching experience. He has one US Patent and an Indian Patent on Tuberculosis to his credit. He is also an author of over 130 research publications. Presently, Professor Bisen is the Chairman of Bisen Biotech and Biopharma (P) Ltd. — a private equity venture which focuses on diagnostic solutions for widespread diseases. Professor Bisen is also the Chairman of the Vikrant Group, which focuses on advancing technical education through technical institutes at Gwalior and Indore, India.
Ruchika Raghuvanshi, PhD, is a Research Scientist at the Defence Research Development Organization, a division of the Indian Ministry of Defence.
Vijayaraghavan, PhD, is Director of the Defence Research Development Establishment, the Defence Research Development Organization, a division of the Indian Ministry of Defence.
Chapter 1Prologue1.1 - Introduction1.2 - Causative factors1.3 - Salient features1.4 - "Emerging" epidemics1.5 - "Re-emerging" epidemics1.6 - Antimicrobial resistance1.7 - Public health implications
Chapter 2Epidemics: Fundamentals2.1 - Introduction2.2 - Definitions2.3 - Types of epidemics2.4 - Epidemiological triad2.5 - Forecasting epidemics2.6 - Contingency plan2.7 - Investigation of epidemics2.8 - Managing epidemics2.9 - Control of epidemics2.10 - Principles of planning emergency services
Chapter 3Disasters and epidemics3.1 - Fundamentals3.2 - Contributory factors3.3 - Investigation of rumours
Chapter 4Biosafety4.1 - Introduction4.2 - Components4.3 - Hand washing4.4 - Preventing needle stick injuries4.5 - Safe transport of biological materials4.6 - Safe decontamination of spills4.7 - Safe handling of dead bodies4.8 - Personal protective equipment4.9 - Management of biomedical waste4.10 - Infection control checklist4.11 - Biosafety levels4.12 - Accreditation of hospitals and laboratories
SECTION-2: RE-EMERGING EPIDEMICS
Chapter 5Tuberculosis5.1 - History of tuberculosis5.2 - Magnitude5.3 - Agent factors5.4 - Host factors and high-risk groups5.5 - Environmental factors5.6 - Mode of transmission5.7 - Pathology and immunology5.8 - Clinical manifestations in adults and children5.9 - Diagnosis5.10 - Directly Observed Treatment, Short Course (DOTS)5.11 - MDR & XDR tuberculosis5.12 - Prevention and control5.13 - Social and cultural factors
Chapter 6Plague6.1 - History of plague6.2 - Magnitude6.3 - Agent factors6.4 - Host factors6.5 - Environmental factors6.6 - Reservoir6.7 - Mode of transmission6.8 - Clinical manifestations6.9 - Diagnosis6.10 - Clinical management6.11 - Prevention and control
SECTION-3: NEWLY EMERGING EPIDEMICS
Chapter 7Leptospirosis7.1 - Introduction7.2 - Magnitude7.3 - Agent factors7.4 - Host and behavioural factors7.5 - Environmental factors7.6 - Mode of transmission7.7 - Pathology and immunology7.8 - Clinical manifestations7.9 - Laboratory diagnosis7.10 - Clinical management7.11 - Surveillance7.12 - Investigation of an outbreak7.13 - Prevention and control
Chapter 8Dengue8.1 - Introduction8.2 - Magnitude8.3 - The dengue virus8.4 - Host factors8.5 - Environmental factors8.6 - Vector biology8.7 - Clinical features8.8 - Laboratory diagnosis8.9 - Clinical management8.10 - Investigation of outbreaks8.11 - Prevention and control
Chapter 9Japanese encephalitis9.1 - Historical aspects9.2 - Magnitude of the problem9.3 - Epidemiology9.4 - Vector biology9.5 - Clinical features9.6 - Differential diagnosis9.7 - Laboratory diagnosis9.8 - Case management9.9 - Prevention and Control
Chapter 10Chikungunya fever10.1 - Magnitude10.2 - Epidemiology10.3 - Clinical features10.4 - Laboratory diagnosis10.5 - Clinical management10.6 - Investigation of outbreaks10.7 - Prevention and control
Chapter 11West Nile fever11.1 - Global scenario11.2 - Epidemiology11.3 - Clinical features11.4 - Laboratory diagnosis11.5 - Clinical management11.6 - Investigation of outbreaks11.7 - Prevention and control
Chapter 12Chandipura virus encephalitis12.1 - Magnitude12.2 - Epidemiology12.3 - Clinical features12.4 - Laboratory diagnosis12.5 - Clinical management12.6 - Investigation of outbreaks12.7 - Prevention and control
Chapter 13Kyasanur forest disease13.1 - Introduction13.2 - Magnitude of the problem13.3 - Epidemiology13.4 - Vector biology13.5 - Clinical features13.6 - Differential diagnosis13.7 - Laboratory diagnosis13.8 - Case management13.9 - Prevention and Control
Chapter 14Hanta virus disease14.1 - Introduction14.2 - Global scenario14.3 - Epidemiology14.4 - Clinical features14.5 - Differential diagnosis14.6 - Laboratory diagnosis14.7 - Case management14.8 - Prevention and Control
Chapter 15Human influenza15.1 - Historical aspects15.2 - Global scenario15.3 - Agent factors15.4 - Host factors15.5 - Environmental factors15.6 - Mode of transmission15.7 - Clinical manifestations15.8 - Laboratory diagnosis15.9 - Clinical management15.10 - Surveillance15.11 - Investigation of an outbreak15.12 - Prevention and control
Chapter 16Avian influenza16.1 - Magnitude of the problem16.2 - H5N1 influenza virus16.3 - Host factors16.4 - Reservoir16.5 - Mode of transmission16.6 - Clinical manifestations16.7 - Laboratory diagnosis16.8 - Clinical management16.9 - Surveillance16.10 - Investigation of an outbreak16.11 - Prevention and control
CHapter 17Paragonimiasis17.1 - Magnitude of the problem17.2 - Paragonimus westermani17.3 - Epidemiology17.4 - Clinical manifestations17.5 - Laboratory diagnosis17.6 - Clinical management17.7 - Public health importance
Chapter 18Melioidosis17.1 - Magnitude of the problem17.2 - Burkholdera pseudomallei17.3 - Epidemiology17.4 - Clinical manifestations17.5 - Laboratory diagnosis17.6 - Clinical management17.7 - Public health importance
SECTION-4: POTENTIAL EPIDEMICS
Chapter 19Biowarfare & bioterrorism19.1 - Historical aspects19.2 - Potential agents19.3 - Epidemiological clues19.4 - Laboratory diagnosis19.5 - Clinical management19.6 - Surveillance and investigation19.7 - Investigation of an outbreak19.8 - Preparedness and containment
Chapter 20Food contamination & food terrorism20.1 - Historical aspects20.2 - Potential agents20.3 - Epidemiological clues20.4 - Laboratory diagnosis20.5 - Clinical management20.6 - Surveillance and investigation20.7 - Investigation of an outbreak20.8 - Preparedness and containment
Chapter 21Antimicrobial resistance21.1 - Introduction21.2 - Global scenario21.3 - Organisms21.4 - Host factors21.5 - Health-related and economic hazards21.6 - Laboratory diagnosis21.8 - Managing antimicrobial resistance21.9 - Prevention and Control
SECTION-5: VECTOR CONTROL METHODS
Chapter 22Conventional methods for mosquito control22.1 - Mosquito: habits & attractants22.2 - Environmental manipulation22.3 - Anti-larval measures22.4 - Chemical adulticides22.5 - Repellents22.6 - Insecticide-impregnated bed nets & screens
Chapter 23New & potential techniques: mosquito control23.1 - Myco-insecticides23.2 - Entomopathogenic bacteria & viruses23.3 - Hormonomimetic & plant-derived substances23.4 - Larvivorous fish and crustaceans23.5 - Dragonfly nymphs23.6 - Protozoa23.7 - Mermithid nematodes23.8 - Predator larvae23.9 - Genetic engineering
Chapter 24Other disease vectors & their control24.1 - Housefly24.2 - Sand fly24.3 - Deer fly24.4 - Black fly24.5 - Tsetse fly24.6 - Water flea (Cyclops)24.7 - Sand flea (Jigger or Chigoe flea)24.8 - Rat flea & Other fleas24.9 - Reduviid bug24.10 - Hard tick24.11 - Soft tick24.11 - Lice24.12 - Cockroach24.13 - Mites (Chiggers)24.14 - General principles of vector control24.15 - Integrated vector control24.16 - Rodents24.17 - Methods for rodent control
The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.
The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.